Detalles de la búsqueda
1.
The addition of androgen deprivation therapy and pelvic lymph node treatment to prostate bed salvage radiotherapy (NRG Oncology/RTOG 0534 SPPORT): an international, multicentre, randomised phase 3 trial.
Lancet;
399(10338): 1886-1901, 2022 05 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-35569466
2.
A phase I study of selinexor combined with weekly carfilzomib and dexamethasone in relapsed/refractory multiple myeloma.
Eur J Haematol;
110(5): 564-570, 2023 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-36726221
3.
Underlying intracranial atherosclerotic disease is associated with worse outcomes in acute large vessel occlusion undergoing endovascular thrombectomy.
J Stroke Cerebrovasc Dis;
32(8): 107227, 2023 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-37437522
4.
Clinically actionable genotypes for anticancer prescribing among >1500 patients with pharmacogenomic testing.
Cancer;
128(8): 1649-1657, 2022 Apr 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-35090043
5.
Efficacy of post-induction therapy for high-risk neuroblastoma patients with end-induction residual disease.
Cancer;
128(15): 2967-2977, 2022 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35665495
6.
Anesthesia providers as stakeholders to adoption of pharmacogenomic information in perioperative care.
Pharmacogenet Genomics;
32(3): 79-86, 2022 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34570085
7.
Phase II Prospective, Open-Label Randomized Controlled Trial Comparing Standard of Care Chemotherapy With and Without Sequential Cytoreductive Interventions for Patients with Oligometastatic Foregut Adenocarcinoma and Undetectable Circulating Tumor Deoxyribose Nucleic Acid (ctDNA) Levels.
Ann Surg Oncol;
2022 Jan 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-34988836
8.
Phase I/II clinical trial of temsirolimus and lenalidomide in patients with relapsed and refractory lymphomas.
Haematologica;
107(7): 1608-1618, 2022 07 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34320785
9.
Prospective study evaluating dynamic changes of cell-free HPV DNA in locoregional viral-associated oropharyngeal cancer treated with induction chemotherapy and response-adaptive treatment.
BMC Cancer;
22(1): 17, 2022 Jan 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-34980038
10.
Pilot Findings of Pharmacogenomics in Perioperative Care: Initial Results From the First Phase of the ImPreSS Trial.
Anesth Analg;
135(5): 929-940, 2022 11 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35213469
11.
Nonparametric inference in the accelerated failure time model using restricted means.
Lifetime Data Anal;
28(1): 23-39, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35018550
12.
A prospective clinical and transcriptomic feasibility study of oral-only hormonal therapy with radiation for unfavorable prostate cancer in men 70 years of age and older or with comorbidity.
Cancer;
127(15): 2631-2640, 2021 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33882144
13.
Household air pollution, ultrasound measurement, fetal biometric parameters and intrauterine growth restriction.
Environ Health;
20(1): 74, 2021 06 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-34187482
14.
Cooperation of genes in HPV16 E6/E7-dependent cervicovaginal carcinogenesis trackable by endoscopy and independent of exogenous estrogens or carcinogens.
Carcinogenesis;
41(11): 1605-1615, 2020 11 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-32221533
15.
A randomized phase 2 study of temsirolimus and cetuximab versus temsirolimus alone in recurrent/metastatic, cetuximab-resistant head and neck cancer: The MAESTRO study.
Cancer;
126(14): 3237-3243, 2020 07 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-32365226
16.
A randomized phase 2 network trial of tivantinib plus cetuximab versus cetuximab in patients with recurrent/metastatic head and neck squamous cell carcinoma.
Cancer;
126(10): 2146-2152, 2020 05 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-32073648
17.
Phase 1 study of lenalidomide plus dose-adjusted EPOCH-R in patients with aggressive B-cell lymphomas with deregulated MYC and BCL2.
Cancer;
125(11): 1830-1836, 2019 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30707764
18.
A UGT1A1 genotype-guided dosing study of modified FOLFIRINOX in previously untreated patients with advanced gastrointestinal malignancies.
Cancer;
125(10): 1629-1636, 2019 05 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-30645764
19.
Phase 1 study of selinexor plus carfilzomib and dexamethasone for the treatment of relapsed/refractory multiple myeloma.
Br J Haematol;
186(4): 549-560, 2019 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-31124580
20.
Differential risk of disease progression between isolated anastomotic ulcers and mild ileal recurrence after ileocolonic resection in patients with Crohn's disease.
Gastrointest Endosc;
90(2): 269-275, 2019 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-30738034